Antonio Guasch, MD
Basic profileAntonio Guasch is a Nephrology physician affiliated with Emory University. OpenAlex indexes 49 publications with 4,048 citations (h-index 27); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingClinical trials
- Belatacept Post Depletional Repopulation to Facilitate Tolerance
Sponsor: Allan D Kirk, MD, PhD
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Apellis Pharmaceuticals, Inc.Program year20251 payment$120
- Aurinia Pharma U.S., Inc.Program year20221 payment$20
- TravereProgram year20211 paymentResearch$1,662
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
52.1%Statin13.9%Atorvastatin Calcium70%Rosuvastatin Calcium17%Pravastatin Sodium9%Simvastatin5%Part D<11 patientsBeta blocker13.7%Carvedilol36%Metoprolol Tartrate34%Metoprolol Succinate26%Labetalol Hcl5%Part D<11 patients+ 6 more classes in this area
Metabolism & gastrointestinal
27.8%Corticosteroid15.2%Prednisone100%Part D≥67 patientsProton pump inhibitor6%Pantoprazole Sodium64%Omeprazole24%Esomeprazole Magnesium12%Part D<11 patients+ 4 more classes in this area
Hormonal (systemic)
6.9%Calcium-sensing Receptor Agonist5.5%Cinacalcet Hcl100%Part D≥17 patientsMineralocorticoids0.8%Fludrocortisone Acetate100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
4 NIH research awards on record, funded 1997–2010 per NIH RePORTER. The latest:
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Decoding CD8 Alloimmunity in the Rejecting Kidney Microenvironment
American Journal of Transplantation
2026 - Kidney transplantation using alemtuzumab, belatacept, and sirolimus: Five-year follow-up
American Journal of Transplantation
2020 - B cell reconstitution following alemtuzumab induction under a belatacept-based maintenance regimen
American Journal of Transplantation
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Allan Levey, MD
Emory University
Craig Coopersmith, MD
Emory University
James Lah, MD
Emory University
Vasilis Babaliaros, MD
Emory University
Laura Svetkey, MD
Duke University
Prasad Devarajan, MD
Cincinnati Children's Hospital Medical Center
Rajesh V. Thakker
Queen Mary University of London
Paul Kimmel, MD
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”